BeStock  
Stocks › URGN

UroGen Pharma Ltd URGN

US equityMarket cap rank #2742
$42.78 +$1.38 (+3.33%)
Pre-market · Oct 6, 4:10 am ET · After hours $42.78 0.00%
Open$41.38
Prev close$41.40
Day range$40.50 – $42.91
Volume1.28M
Market cap$2.09B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-21.7x
CheapRich

Near the bottom of its 5-year range · 2nd percentile, 5-year average -4.6x

P/E over five years

-26x-17x-8x2xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$39.27
Price vs. fair value+8.9%Trading above the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PE -21.72 22.08 -4.59 2% (cheaper than usual) –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$39.27
Economic moatNone
UncertaintyHigh

Discussion

No comments yet — be the first to weigh in on URGN.

Leave a comment

Scroll to Top